We are live on ! Find out more

Micro Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization

Micro Cap Drug Manufacturers - General Stocks at a Glance

Large drug manufacturers sell diversified portfolios of branded medicines backed by deep development pipelines. Patent lives set the clock: blockbuster franchises fund the R&D and acquisitions needed to outrun expirations, supporting durable margins and dividends.

There are 30 micro cap Drug Manufacturers - General stocks — companies in the Drug Manufacturers - General industry with a market cap under $250M — worth a combined $1.18B.

The largest by market cap are Protalix BioTherapeutics (PLX) at $185M, Armata Pharmaceuticals (ARMP) at $167M and Pelthos Therapeutics (PTHS) at $99.2M.

Among institutional investors, Armata Pharmaceuticals (ARMP) drew the most net new fund positions in Q2 2026: 19 funds opened new positions, taking total fund holders up 8 (18%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.